Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution - Pernas, Sonia; Petit, Anna; Climent, Fina; Paré, Laia; Perez-Martin, J.; Ventura, Luz; Bergamino, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez-Ortega, Adela; Stradella, Agostina; et al. (Frontiers in Oncology, 2019)